Bioavailability of hydrochlorothiazide from pellets, made by extrusion/spheronisation, containing polyethylene glycol 400 as a dissolution enhancer.
Vervaet
C
C
Laboratory of Pharmaceutical Technology, University of Gent, Belgium.
Remon
J P
JP
D000277:Adjuvants, Pharmaceutic / Q000493:pharmacokinetics*; D000284:Administration, Oral; D000328:Adult; D001682:Biological Availability; D018592:Cross-Over Studies; D004339:Drug Compounding; D004343:Drug Implants; D006801:Humans; D006852:Hydrochlorothiazide / Q000097:blood / Q000493:pharmacokinetics*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000493:pharmacokinetics*; D011897:Random Allocation; D012995:Solubility
D000277:Adjuvants, Pharmaceutic; D004343:Drug Implants; D006852:Hydrochlorothiazide; D011092:Polyethylene Glycols